Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic Union Bankshares A Pref | AUB-A | Nov 26, 2024 | 24.80 | -0.40 |
Atlantica Sustainable Infrastructure | AY | Nov 26, 2024 | 22.14 | 0.00 |
Atlanticus | ATLC | Nov 26, 2024 | 57.22 | +0.37 |
Atlanticus B Pref | ATLCP | Nov 26, 2024 | 23.84 | -0.03 |
Atlas Energy Solutions | AESI | Nov 26, 2024 | 23.55 | -0.72 |
Atlas Lithium | ATLX | Nov 26, 2024 | 6.76 | -6.24 |
Atlas Pref D | ATCO-D | Nov 26, 2024 | 24.93 | -0.99 |
Atlas Pref H | ATCO-H | Nov 26, 2024 | 25.06 | +0.24 |
AtlasClear Holdings | ATCH | Nov 26, 2024 | 0.20 | +2.25 |
Atlassian A | TEAM | Nov 26, 2024 | 262.23 | +0.47 |
Atmos Energy | ATO | Nov 26, 2024 | 150.33 | +0.10 |
Atmus Filtration Technologies | ATMU | Nov 26, 2024 | 43.72 | -0.79 |
ATN International | ATNI | Nov 26, 2024 | 19.74 | -0.60 |
Atomera | ATOM | Nov 26, 2024 | 6.15 | -8.21 |
Atossa Therapeutics | ATOS | Nov 26, 2024 | 1.29 | +0.78 |
Atour Lifestyle ADR | ATAT | Nov 26, 2024 | 25.00 | -3.55 |
ATRenew A ADR | RERE | Nov 26, 2024 | 3.12 | +13.87 |
AtriCure | ATRC | Nov 26, 2024 | 35.79 | -0.61 |
ATS Corporation | ATS | Nov 26, 2024 | 30.12 | -5.96 |
aTyr Pharma | ATYR | Nov 26, 2024 | 3.29 | +5.45 |
Auburn National Bank | AUBN | Nov 26, 2024 | 23.66 | +3.27 |
Auddia | AUUD | Nov 26, 2024 | 0.55 | -0.51 |
AudioCodes | AUDC | Nov 26, 2024 | 9.33 | +0.32 |
AudioEye | AEYE | Nov 26, 2024 | 26.29 | -0.72 |
Auna S.A.A | AUNA | Nov 26, 2024 | 7.51 | +6.07 |
Aura Biosciences | AURA | Nov 26, 2024 | 8.96 | +0.90 |
Aura FAT Projects Acquisition A | AFAR | Nov 26, 2024 | 11.68 | 0.00 |
Aurinia Pharmaceuticals | AUPH | Nov 26, 2024 | 8.71 | 0.00 |
Aurora Cannabis | ACB | Nov 26, 2024 | 4.41 | -3.50 |
Aurora Innovation A | AUR | Nov 26, 2024 | 6.05 | -6.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.